Table of Contents

1 Study Coverage

• 1.1 Nimodipine Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Nimodipine Market Size Growth Rate by Product
  • 1.4.2 Capsule
  • 1.4.3 Solution
  • 1.4.4 Tablets
• 1.5 Market by End User
  • 1.5.1 Global Nimodipine Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Pharmacy
  • 1.5.4 Clinics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Nimodipine Market Size
  • 2.1.1 Global Nimodipine Revenue 2014-2025
  • 2.1.2 Global Nimodipine Sales 2014-2025
• 2.2 Nimodipine Growth Rate by Regions
  • 2.2.1 Global Nimodipine Sales by Regions
  • 2.2.2 Global Nimodipine Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Nimodipine Sales by Manufacturers
  • 3.1.1 Nimodipine Sales by Manufacturers
  • 3.1.2 Nimodipine Sales Market Share by Manufacturers
  • 3.1.3 Global Nimodipine Market Concentration Ratio (CR5 and HHI)
• 3.2 Nimodipine Revenue by Manufacturers
  • 3.2.1 Nimodipine Revenue by Manufacturers (2014-2019)
  • 3.2.2 Nimodipine Revenue Share by Manufacturers (2014-2019)
• 3.3 Nimodipine Price by Manufacturers
• 3.4 Nimodipine Manufacturing Base Distribution, Product Types
  • 3.4.1 Nimodipine Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Nimodipine Product Type
  • 3.4.3 Date of International Manufacturers Enter into Nimodipine Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Nimodipine Sales by Product
• 4.2 Global Nimodipine Revenue by Product
• 4.3 Nimodipine Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Nimodipine Breakdown Data by End User

6 North America

• 6.1 North America Nimodipine by Countries
  • 6.1.1 North America Nimodipine Sales by Countries
  • 6.1.2 North America Nimodipine Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Nimodipine by Product
• 6.3 North America Nimodipine by End User

7 Europe

• 7.1 Europe Nimodipine by Countries
  • 7.1.1 Europe Nimodipine Sales by Countries
  • 7.1.2 Europe Nimodipine Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Nimodipine by Product
• 7.3 Europe Nimodipine by End User

8 Asia Pacific

• 8.1 Asia Pacific Nimodipine by Countries
  • 8.1.1 Asia Pacific Nimodipine Sales by Countries
  • 8.1.2 Asia Pacific Nimodipine Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Nimodipine by Product
• 8.3 Asia Pacific Nimodipine by End User

9 Central & South America

• 9.1 Central & South America Nimodipine by Countries
  • 9.1.1 Central & South America Nimodipine Sales by Countries
  • 9.1.2 Central & South America Nimodipine Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Nimodipine by Product
• 9.3 Central & South America Nimodipine by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Nimodipine by Countries
  • 10.1.1 Middle East and Africa Nimodipine Sales by Countries
  • 10.1.2 Middle East and Africa Nimodipine Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Nimodipine by Product
• 10.3 Middle East and Africa Nimodipine by End User

11 Company Profiles

• 11.1 Sun Pharm Inds
  • 11.1.1 Sun Pharm Inds Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Sun Pharm Inds Nimodipine Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Sun Pharm Inds Nimodipine Products Offered
  • 11.1.5 Sun Pharm Inds Recent Development
• 11.2 Heritage Pharms
  • 11.2.1 Heritage Pharms Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Heritage Pharms Nimodipine Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Heritage Pharms Nimodipine Products Offered
  • 11.2.5 Heritage Pharms Recent Development
• 11.3 Bionpharma
  • 11.3.1 Bionpharma Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Bionpharma Nimodipine Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Bionpharma Nimodipine Products Offered
  • 11.3.5 Bionpharma Recent Development
• 11.4 Arbor Pharms
  • 11.4.1 Arbor Pharms Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Arbor Pharms Nimodipine Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Arbor Pharms Nimodipine Products Offered
  • 11.4.5 Arbor Pharms Recent Development
• 11.5 Thepharmanetwork
  • 11.5.1 Thepharmanetwork Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Thepharmanetwork Nimodipine Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Thepharmanetwork Nimodipine Products Offered
  • 11.5.5 Thepharmanetwork Recent Development
• 11.6 Sofgen Pharms
  • 11.6.1 Sofgen Pharms Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Sofgen Pharms Nimodipine Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Sofgen Pharms Nimodipine Products Offered
  • 11.6.5 Sofgen Pharms Recent Development
• 11.7 Bayer Vital GmbH
  • 11.7.1 Bayer Vital GmbH Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Bayer Vital GmbH Nimodipine Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Bayer Vital GmbH Nimodipine Products Offered
  • 11.7.5 Bayer Vital GmbH Recent Development

12 Future Forecast

• 12.1 Nimodipine Market Forecast by Regions
  • 12.1.1 Global Nimodipine Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Nimodipine Revenue Forecast by Regions 2019-2025
• 12.2 Nimodipine Market Forecast by Product
  • 12.2.1 Global Nimodipine Sales Forecast by Product 2019-2025
  • 12.2.2 Global Nimodipine Revenue Forecast by Product 2019-2025
• 12.3 Nimodipine Market Forecast by End User
• 12.4 North America Nimodipine Forecast
• 12.5 Europe Nimodipine Forecast
• 12.6 Asia Pacific Nimodipine Forecast
• 12.7 Central & South America Nimodipine Forecast
• 12.8 Middle East and Africa Nimodipine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Nimodipine Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Nimodipine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Nimodipine market based on company, product type, end user and key regions.

This report studies the global market size of Nimodipine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nimodipine in these regions.
This research report categorizes the global Nimodipine market by top players/brands, region, type and end user. This report also studies the global Nimodipine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sun Pharm Inds
Heritage Pharms
Bionpharma
Arbor Pharms
Thepharmanetwork
Sofgen Pharms
Bayer Vital GmbH

Market size by Product
Capsule
Solution
Tablets
Market size by End User
Hospital
Pharmacy
Clinics

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Nimodipine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Nimodipine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Nimodipine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Nimodipine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Nimodipine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nimodipine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.